Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection
This study has been completed.
First Posted: February 22, 2010
Last Update Posted: May 31, 2012
Information provided by (Responsible Party):